RESEARCHER PROFILE

Andrei Carvalho Sposito

← Back to Universidade Estadual de Campinas (UNICAMP)

A

Universidade Estadual de Campinas (UNICAMP)

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction ResearchDiabetes, Cardiovascular Risks, and LipoproteinsBlood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Andrei Carvalho Sposito works in Lipoproteins and Cardiovascular Health, Acute Myocardial Infarction Research, Diabetes, Cardiovascular Risks, and Lipoproteins, Blood Pressure and Hypertension Studies, Cardiovascular Health and Disease Prevention. Recorded institutional associations include Universidade de São Paulo, Universidade Estadual de Campinas (UNICAMP), Universidade Católica de Brasília.

506Publications
11,566Citations
45H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Diretrizes Brasileiras de Hipertensão Arterial – 2020

    2021 · 1,068 citations
  2. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

    2020 · 904 citations
  3. ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017

    2017 · 633 citations
  4. Evolution and epidemic spread of SARS-CoV-2 in Brazil

    2020 · 572 citations
  5. IV Diretriz Brasileira sobre Dislipidemias e Prevenção da Aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia

    2007 · 558 citations
  6. V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose

    2013 · 454 citations
  7. Updated Cardiovascular Prevention Guideline of the Brazilian Society of Cardiology - 2019

    2019 · 434 citations
  8. A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?

    2013 · 352 citations
  9. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality -- a systematic review

    2014 · 305 citations
  10. Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte Response through a HIF-1α/Glycolysis-Dependent Axis

    2020 · 176 citations
  11. GLP-1RAs in type 2 diabetes: mechanisms that underlie cardiovascular effects and overview of cardiovascular outcome data

    2018 · 170 citations
  12. Statin Therapy in Acute Coronary Syndromes

    2002 · 159 citations
  13. Anthracycline Therapy Is Associated With Cardiomyocyte Atrophy and Preclinical Manifestations of Heart Disease

    2018 · 153 citations
  14. Role of LOX-1 (Lectin-Like Oxidized Low-Density Lipoprotein Receptor 1) as a Cardiovascular Risk Predictor

    2020 · 153 citations
  15. Cardiovascular effects of Glucagon-like peptide 1 (GLP-1) receptor agonists

    2014 · 143 citations
  16. Additional reduction in blood pressure after cholesterol-lowering treatment by statins (lovastatin or pravastatin) in hypercholesterolemic patients using angiotensin-converting enzyme inhibitors (enalapril or lisinopril)

    1999 · 140 citations
  17. Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome

    2018 · 131 citations
  18. Hypertension and dyslipidaemia in obesity and insulin resistance: Pathophysiology, impact on atherosclerotic disease and pharmacotherapy

    2008 · 122 citations
  19. Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors and Incident Type 2 Diabetes: A Systematic Review and Meta-analysis With Over 96,000 Patient-Years

    2017 · 121 citations
  20. Guideline For Stable Coronary Artery Disease

    2014 · 88 citations
  21. Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

    2021 · 87 citations
  22. Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes

    2025 · 79 citations
  23. Vitamin D for the prevention of cardiovascular disease: Are we ready for that?

    2015 · 78 citations
  24. Elevated Glucose Levels Favor Sars-Cov-2 Infection and Monocyte Response Through a Hif-1α/Glycolysis Dependent Axis

    2020 · 75 citations
  25. SARS-CoV-2 uses CD4 to infect T helper lymphocytes

    2023 · 74 citations

← Return to the university profile